Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IMVT |
---|---|---|
09:32 ET | 6757 | 25.17 |
09:36 ET | 1048 | 25.325 |
09:38 ET | 1000 | 25.28 |
09:39 ET | 800 | 25.41 |
09:41 ET | 100 | 25.455 |
09:43 ET | 300 | 25.48 |
09:45 ET | 963 | 25.645 |
09:48 ET | 2621 | 25.68 |
09:50 ET | 100 | 25.61 |
09:52 ET | 300 | 25.55 |
09:54 ET | 800 | 25.34 |
09:56 ET | 1609 | 25.545 |
09:57 ET | 100 | 25.53 |
09:59 ET | 510 | 25.58 |
10:03 ET | 200 | 25.63 |
10:06 ET | 100 | 25.59 |
10:08 ET | 1100 | 25.57 |
10:10 ET | 900 | 25.62 |
10:12 ET | 400 | 25.475 |
10:14 ET | 100 | 25.45 |
10:17 ET | 200 | 25.49 |
10:19 ET | 518 | 25.53 |
10:21 ET | 100 | 25.66 |
10:24 ET | 600 | 25.66 |
10:26 ET | 369 | 25.72 |
10:30 ET | 200 | 25.74 |
10:32 ET | 1359 | 25.695 |
10:35 ET | 813 | 25.75 |
10:37 ET | 1702 | 25.71 |
10:39 ET | 300 | 25.76 |
10:42 ET | 358 | 25.84 |
10:44 ET | 600 | 25.83 |
10:46 ET | 100 | 25.83 |
10:48 ET | 300 | 25.82 |
10:50 ET | 800 | 25.78 |
10:51 ET | 700 | 25.77 |
10:55 ET | 500 | 25.69 |
10:57 ET | 1944 | 25.63 |
11:00 ET | 1130 | 25.64 |
11:02 ET | 400 | 25.59 |
11:04 ET | 100 | 25.59 |
11:06 ET | 494 | 25.6 |
11:08 ET | 400 | 25.52 |
11:09 ET | 1251 | 25.555 |
11:11 ET | 2570 | 25.45 |
11:13 ET | 100 | 25.45 |
11:15 ET | 246 | 25.4569 |
11:18 ET | 200 | 25.445 |
11:20 ET | 810 | 25.41 |
11:22 ET | 3951 | 25.425 |
11:24 ET | 1000 | 25.5 |
11:26 ET | 663 | 25.5 |
11:27 ET | 3200 | 25.4399 |
11:29 ET | 492 | 25.34 |
11:31 ET | 100 | 25.345 |
11:33 ET | 17802 | 25.515 |
11:36 ET | 637 | 25.495 |
11:38 ET | 126 | 25.47 |
11:40 ET | 820 | 25.39 |
11:42 ET | 1300 | 25.47 |
11:44 ET | 300 | 25.44 |
11:45 ET | 100 | 25.435 |
11:47 ET | 100 | 25.4 |
11:51 ET | 447 | 25.42 |
11:56 ET | 200 | 25.445 |
11:58 ET | 200 | 25.46 |
12:00 ET | 1424 | 25.39 |
12:02 ET | 2729 | 25.37 |
12:03 ET | 800 | 25.37 |
12:05 ET | 1396 | 25.36 |
12:07 ET | 3035 | 25.32 |
12:09 ET | 3175 | 25.3 |
12:12 ET | 2584 | 25.34 |
12:14 ET | 3565 | 25.31 |
12:16 ET | 1800 | 25.31 |
12:18 ET | 1511 | 25.2 |
12:20 ET | 100 | 25.195 |
12:21 ET | 200 | 25.17 |
12:23 ET | 810 | 25.235 |
12:25 ET | 1124 | 25.225 |
12:27 ET | 900 | 25.23 |
12:30 ET | 2865 | 25.29 |
12:32 ET | 626 | 25.26 |
12:34 ET | 300 | 25.205 |
12:36 ET | 915 | 25.2 |
12:38 ET | 227 | 25.18 |
12:39 ET | 400 | 25.17 |
12:41 ET | 1075 | 25.18 |
12:43 ET | 200 | 25.2 |
12:45 ET | 100 | 25.2 |
12:50 ET | 1686 | 25.1 |
12:52 ET | 400 | 25.135 |
12:54 ET | 2002 | 25.11 |
12:56 ET | 1519 | 25.09 |
12:57 ET | 900 | 25.115 |
12:59 ET | 600 | 25.14 |
01:01 ET | 200 | 25.16 |
01:03 ET | 500 | 25.23 |
01:06 ET | 100 | 25.24 |
01:10 ET | 100 | 25.225 |
01:12 ET | 1189 | 25.21 |
01:14 ET | 1100 | 25.21 |
01:15 ET | 200 | 25.21 |
01:19 ET | 2800 | 25.18 |
01:24 ET | 800 | 25.225 |
01:26 ET | 1135 | 25.2 |
01:28 ET | 1327 | 25.19 |
01:30 ET | 400 | 25.13 |
01:32 ET | 1356 | 25.14 |
01:33 ET | 200 | 25.135 |
01:35 ET | 2428 | 25.16 |
01:37 ET | 100 | 25.215 |
01:39 ET | 400 | 25.24 |
01:42 ET | 1800 | 25.24 |
01:44 ET | 100 | 25.23 |
01:46 ET | 1716 | 25.26 |
01:48 ET | 600 | 25.22 |
01:50 ET | 500 | 25.21 |
01:51 ET | 729 | 25.17 |
01:53 ET | 784 | 25.18 |
01:57 ET | 700 | 25.22 |
02:00 ET | 809 | 25.21 |
02:02 ET | 3200 | 25.195 |
02:04 ET | 8613 | 25.165 |
02:06 ET | 700 | 25.16 |
02:08 ET | 500 | 25.18 |
02:09 ET | 2199 | 25.215 |
02:11 ET | 757 | 25.1698 |
02:13 ET | 300 | 25.195 |
02:18 ET | 200 | 25.22 |
02:22 ET | 400 | 25.21 |
02:24 ET | 537 | 25.25 |
02:26 ET | 13240 | 25.22 |
02:27 ET | 1095 | 25.19 |
02:29 ET | 1027 | 25.2 |
02:31 ET | 23040 | 25.28 |
02:33 ET | 2099 | 25.23 |
02:36 ET | 900 | 25.2 |
02:38 ET | 1049 | 25.23 |
02:40 ET | 2474 | 25.215 |
02:42 ET | 1900 | 25.195 |
02:44 ET | 100 | 25.18 |
02:45 ET | 300 | 25.175 |
02:47 ET | 700 | 25.15 |
02:49 ET | 600 | 25.15 |
02:51 ET | 635 | 25.15 |
02:54 ET | 2186 | 25.18 |
02:56 ET | 400 | 25.155 |
02:58 ET | 3625 | 25.09 |
03:00 ET | 828 | 25.05 |
03:02 ET | 1246 | 25.05 |
03:03 ET | 4364 | 25.045 |
03:05 ET | 232 | 25.05 |
03:07 ET | 1500 | 25.05 |
03:09 ET | 600 | 25.05 |
03:12 ET | 208 | 25.045 |
03:14 ET | 900 | 25.025 |
03:16 ET | 3872 | 25 |
03:18 ET | 400 | 25.01 |
03:20 ET | 900 | 24.95 |
03:21 ET | 3246 | 24.975 |
03:23 ET | 1838 | 24.95 |
03:25 ET | 400 | 24.955 |
03:27 ET | 100 | 24.97 |
03:30 ET | 2300 | 25 |
03:32 ET | 1736 | 25.035 |
03:34 ET | 1834 | 25.055 |
03:36 ET | 20457 | 25.095 |
03:38 ET | 2014 | 25.125 |
03:39 ET | 3981 | 25.23 |
03:41 ET | 5695 | 25.15 |
03:43 ET | 1342 | 25.165 |
03:45 ET | 9281 | 25.21 |
03:48 ET | 1472 | 25.245 |
03:50 ET | 1200 | 25.28 |
03:52 ET | 3393 | 25.22 |
03:54 ET | 8991 | 25.25 |
03:56 ET | 14659 | 25.19 |
03:57 ET | 8810 | 25.15 |
03:59 ET | 144711 | 25.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunovant Inc | 3.7B | -13.3x | --- |
Crinetics Pharmaceuticals Inc | 3.7B | -11.9x | --- |
Merus NV | 3.5B | -19.4x | --- |
Dyne Therapeutics Inc | 3.2B | -7.8x | --- |
Immunitybio Inc | 4.4B | -5.8x | --- |
Biohaven Ltd | 3.1B | -4.9x | --- |
Immunovant, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments for patients with autoimmune diseases. Its product pipeline includes batoclimab and IMVT-1402, both of which are novel, fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor (FcRn). Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD). Its lead product candidate IMVT-1402 has also been observed to reduce IgG antibody levels in a Phase I clinical trial conducted in healthy adults. IMVT-1402 is a fully human monoclonal antibody that inhibits FcRn.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 146.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-1.89 |
Book Value | $4.24 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.